Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

STRIDES PHARMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 36
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 40
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

MSN

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 37
  • 0 comments

FDA approve NELARABINE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 32
  • 0 comments

FDA approve ERLOTINIB HYDROCHLORIDE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • Sept. 17, 2024, 05:31 UTC
  • 37
  • 0 comments

FDA approve CYCLOBENZAPRINE HYDROCHLORIDE

Comment Full text

ELI LILLY AND CO

  • FDA Approval
  • Sept. 16, 2024, 11:31 UTC
  • 38
  • 0 comments

FDA approve LEBRIKIZUMAB-LBKZ

Comment Full text

BIOGEN INC

  • FDA Approval
  • Sept. 16, 2024, 11:11 UTC
  • 37
  • 0 comments

FDA approve DIROXIMEL FUMARATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 39
  • 0 comments

FDA approve METHOTREXATE

Comment Full text

J AND J CONSUMER INC

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 35
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 309
  • 310
  • 311
  • 312
  • 313
  • Next

Search

News categories

  • Technical Exchange News(10609)
  • Event(2032)
  • SEC News(185155)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122565)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin